{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"510.000","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"162,769,979","primaryexch":"香港交易所","ric":"6990.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BPXZ192","am":"556.95","iv":"","ew_strike":"","as":"486.400","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"486.200","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-28 00:06:03.0","lo52":"152.000","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"劉革新","underlying_ric":"6990.HK","hi52":"541.500","issuer_name":"四川科倫博泰生物醫藥股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"478.200","mkt_cap":"79.13","f_aum_hkd":null,"ew_sub_per_to":"","ls":"486.200","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-21.800","aum":"","issued_shares_class_B":null,"vo":"1.14","secondary_listing_flag":false,"listing_date":"2023年7月11日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"四川科倫博泰生物醫藥股份有限公司 - B - H股","nm_s":"科倫博泰生物－Ｂ","sym":"6990","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.200","strike_price":"","summary":"四川科倫博泰生物醫藥股份有限公司是一家主要從事新藥業務的研發、生產和銷售的中國公司。該公司主要從事腫瘤學、免疫學及其他治療領域的創新藥物的研發、製造及商業化。該公司的產品為抗體藥物偶聯物（ADC）SKB264及A166。該公司產品主要用於乳腺癌、非小細胞肺癌、胃腸道癌等非腫瘤疾病的治療。","op":"500.000","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國四川省<br/>成都市溫江區<br/>成都海峽兩岸科技產業開發園<br/>新華大道666號","pc":"-4.29","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"508.000","isin":"CNE1000062J1","moneyness":""}},"qid":"1759074018932"}
